Continuous glucose monitoring (CGM) systems are wearable medical devices that track glucose levels in real time, providing dynamic, continuous insight into a person’s glycemic patterns. They are widely used in type 1 and type 2 diabetes management and are transforming diabetes care by improving glucose control, reducing hypoglycemia, and enabling data-driven therapy decisions.
Below is a clear, structured overview.
What a CGM System Is
A CGM system measures interstitial glucose (the fluid around cells), not blood glucose directly. It provides:
-
A glucose reading every 1–5 minutes
-
Trend arrows (direction and rate of change)
-
Graphs and alerts
-
Data sharing with apps, smartwatches, caregivers, and insulin pumps
Most systems consist of:
-
Sensor – tiny filament inserted under the skin
-
Transmitter – sends readings to a receiver or smartphone
-
Display device – phone, smartwatch, or dedicated reader
Many modern CGMs are factory calibrated and require no fingerstick tests.
How CGMs Work (Simple Explanation)
-
The sensor has a tiny electrode.
-
Enzymes (e.g., glucose oxidase) react with glucose in interstitial fluid.
-
This reaction generates an electrical signal proportional to glucose concentration.
-
Algorithms convert this signal into a glucose reading.
-
Data is transmitted and visualized continuously.
Because readings are from interstitial fluid, not blood, there is a 5–10 minute delay during rapid glucose changes.
Key Benefits of CGM
1. Real-time awareness
Users can see:
-
Current glucose
-
Rising, falling, or stable trends
-
How meals, exercise, or insulin affect levels
2. Hypoglycemia prevention
Customizable alerts can warn users before they go low.
3. Improved glycemic control
CGMs support:
-
Lower HbA1c
-
Higher time-in-range
-
Fewer severe highs and lows
4. Data-driven therapies
CGM data informs:
-
Insulin dosing adjustments
-
Behavioral changes
-
Healthcare provider decisions
5. Integration with insulin delivery
Some CGMs integrate with:
-
Insulin pumps
-
Hybrid closed-loop systems (“artificial pancreas”)
These systems use CGM data to automatically adjust insulin delivery.
Types of CGM Devices
1. Real-time CGM (rtCGM)
Provides continuous streams of data in real time.
Examples:
-
Dexcom G6 / G7
-
Medtronic Guardian Sensor
-
Abbott Libre 3 (real-time version)
2. Intermittently scanned CGM (isCGM / Flash Glucose Monitoring)
User scans a sensor to get data; some now also provide optional alarms.
Examples:
-
Abbott FreeStyle Libre 2 & Libre 14-day
Limitations of CGM
-
Lag time vs. blood glucose, especially during rapid changes
-
Skin irritation or adhesive issues
-
Sensor warm-up time (1–2 hours typically)
-
Cost / insurance coverage
-
Inaccuracy during dehydration or pressure on the sensor (“compression lows”)
While CGMs are highly accurate, occasional fingerstick checks may still be needed.
CGM in Clinical Use
Used for:
-
Insulin-treated diabetes (type 1 and type 2)
-
Gestational diabetes (in some cases)
-
Personalized insulin adjustments
-
Hospital and critical care settings (growing use)
Trend metrics such as time in range (TIR) are now internationally recognized quality measures.
Integration With Other Systems
Modern diabetes technology ecosystems combine:
-
CGMs
-
Smart pens
-
Insulin pumps
-
Smartphone applications
-
Cloud dashboards
Hybrid closed-loop systems (e.g., Tandem Control-IQ, Medtronic 780G) use CGM data to automatically adjust basal insulin and sometimes deliver automatic correction boluses.
Future Directions
-
Fully closed-loop “artificial pancreas”
-
Longer wear sensors (up to 15–21 days)
-
Non-invasive optical CGM (research stage)
-
Improved accuracy and stability
-
Better cybersecurity and data integration
Continuous glucose monitoring systems provide real-time glucose tracking, trend information, and automated alerts that dramatically improve diabetes management. They reduce hypoglycemia, improve time-in-range, integrate with insulin delivery systems, and support personalized treatment decisions.
Leave a Reply